Literature DB >> 28748155

How far have we come with bioresorbable vascular scaffolds, and where should we go?

Jeehoon Kang1, Kyung Woo Park1, Hyo Soo Kim1.   

Abstract

Year:  2017        PMID： 28748155      PMCID： PMC5509923          DOI： 10.21037/cdt.2017.01.11

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  15 in total

1.  Vascular response of the segments adjacent to the proximal and distal edges of the ABSORB everolimus-eluting bioresorbable vascular scaffold: 6-month and 1-year follow-up assessment: a virtual histology intravascular ultrasound study from the first-in-man ABSORB cohort B trial.

Authors:  Bill D Gogas; Patrick W Serruys; Roberto Diletti; Vasim Farooq; Salvatore Brugaletta; Maria D Radu; Jung Ho Heo; Yoshinobu Onuma; Robert-Jan M van Geuns; Evelyn Regar; Bernard De Bruyne; Bernard Chevalier; Leif Thuesen; Pieter C Smits; Dariusz Dudek; Jacques Koolen; Stefan Windecker; Robert Whitbourn; Karine Miquel-Hebert; Cecile Dorange; Richard Rapoza; Hector M Garcia-Garcia; Dougal McClean; John A Ormiston
Journal:  JACC Cardiovasc Interv       Date:  2012-06       Impact factor: 11.195

Review 2.  2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Henry H Ting; Patrick T O'Gara; Frederick G Kushner; Deborah D Ascheim; Ralph G Brindis; Donald E Casey; Mina K Chung; James A de Lemos; Deborah B Diercks; James C Fang; Barry A Franklin; Christopher B Granger; Harlan M Krumholz; Jane A Linderbaum; David A Morrow; L Kristin Newby; Joseph P Ornato; Narith Ou; Martha J Radford; Jacqueline E Tamis-Holland; Carl L Tommaso; Cynthia M Tracy; Y Joseph Woo; David X Zhao
Journal:  J Am Coll Cardiol       Date:  2015-10-21       Impact factor: 24.094

3.  Who Is Thrombogenic: The Scaffold or the Doctor? Back to the Future!

Authors:  Antonio Colombo; Neil Ruparelia
Journal:  JACC Cardiovasc Interv       Date:  2016-01-11       Impact factor: 11.195

4.  Bioresorbable Coronary Scaffold Thrombosis: Multicenter Comprehensive Analysis of Clinical Presentation, Mechanisms, and Predictors.

Authors:  Serban Puricel; Florim Cuculi; Melissa Weissner; Axel Schmermund; Peiman Jamshidi; Tobias Nyffenegger; Harald Binder; Holger Eggebrecht; Thomas Münzel; Stephane Cook; Tommaso Gori
Journal:  J Am Coll Cardiol       Date:  2016-03-01       Impact factor: 24.094

5.  Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.

Authors:  Yoshinobu Onuma; Dariusz Dudek; Leif Thuesen; Mark Webster; Koen Nieman; Hector M Garcia-Garcia; John A Ormiston; Patrick W Serruys
Journal:  JACC Cardiovasc Interv       Date:  2013-10       Impact factor: 11.195

6.  Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

Authors:  Salvatore Brugaletta; Tommaso Gori; Adrian F Low; Petr Tousek; Eduardo Pinar; Josep Gomez-Lara; Giancarla Scalone; Eberhard Schulz; Mark Y Chan; Viktor Kocka; Jose Hurtado; Juan Antoni Gomez-Hospital; Thomas Münzel; Chi-Hang Lee; Angel Cequier; Mariano Valdés; Petr Widimsky; Patrick W Serruys; Manel Sabaté
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

7.  Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria.

Authors:  Robin P Kraak; Maik J Grundeken; Mariëlla E Hassell; Joëlle Elias; Karel T Koch; José P Henriques; Jan J Piek; Jan Baan; Marije M Vis; Jan G P Tijssen; Robbert J de Winter; Joanna J Wykrzykowska
Journal:  EuroIntervention       Date:  2016-08-05       Impact factor: 6.534

Review 8.  Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold: A Systematic Review and Meta-Analysis.

Authors:  Michael J Lipinski; Ricardo O Escarcega; Nevin C Baker; Hadiya A Benn; Michael A Gaglia; Rebecca Torguson; Ron Waksman
Journal:  JACC Cardiovasc Interv       Date:  2016-01-11       Impact factor: 11.195

Review 9.  Bioresorbable scaffolds: rationale, current status, challenges, and future.

Authors:  Javaid Iqbal; Yoshinobu Onuma; John Ormiston; Alexandre Abizaid; Ron Waksman; Patrick Serruys
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

10.  Biocorrodible metals for coronary revascularization: Lessons from PROGRESS-AMS, BIOSOLVE-I, and BIOSOLVE-II.

Authors:  Yasir H Bouchi; Bill D Gogas
Journal:  Glob Cardiol Sci Pract       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.